KPMA urged to come up with countermeasures over price-cut plan and KORUS FTA

The new executives of the Korea Pharmaceutical Manufacturers Association needs to assess the damage that the government’s impending price-cut plan and Korea’s free trade deals with the U.S. would cause in the pharmaceutical industry sector in the future and map out proper countermeasures, industry officials said yesterday.

“The KPMA new chairman Yoon Suk-geun should produce policies that co...